Kale, S. Et Al. 2020. HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.. Naunyn-Schmiedeberg's archives of pharmacology , vol.393, no.2 , 253-262.

Kale, S., KORCUM, A. F., DUNDAR, E., & ERİN, N., (2020). HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.. Naunyn-Schmiedeberg's archives of pharmacology , vol.393, no.2, 253-262.

Kale, ŞULE Et Al. "HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.," Naunyn-Schmiedeberg's archives of pharmacology , vol.393, no.2, 253-262, 2020

Kale, ŞULE Et Al. "HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.." Naunyn-Schmiedeberg's archives of pharmacology , vol.393, no.2, pp.253-262, 2020

Kale, S. Et Al. (2020) . "HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.." Naunyn-Schmiedeberg's archives of pharmacology , vol.393, no.2, pp.253-262.

@article{article, author={ŞULE KALE Et Al. }, title={HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.}, journal={Naunyn-Schmiedeberg's archives of pharmacology}, year=2020, pages={253-262} }